pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
IRINOTECAN HYDROCHLOIDE
IRINOTECAN HYDROCHLOIDE
no indication
GLAND
Phase 2
IRL-201104
Eosinophilic Esophagitis
Revolo Biotherapeutics Ltd
Phase 2
IRX-101
Eye Infections
iRenix Medical Inc
Phase 2
IRX-4204
← prev
page 97 of 231
next →
Pain
89
Neurology
1
Parkinson's Disease
Io Therapeutics Inc
Preclinical
IS-101
InvisiMask
Coronavirus Disease 2019 (COVID-19)
InvisiShield Technologies Ltd
Phase 1
ISB-2001
Refractory Multiple Myeloma
$ABBV
AbbVie Inc.
Phase 1
ISM-3412
Solid Tumor
InSilico Medicine
Phase 1
ISM-6331
Malignant Mesothelioma
InSilico Medicine
Preclinical
ISM-9274
Solid Tumor
InSilico Medicine
Phase 2
ISN-001
Diabetic Foot Ulcers
Anterogen Co Ltd
ISOLYTE S PH 7.4
ISOLYTE S PH 7.4 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE)
no indication
B BRAUN
Phase 2
ISP-001
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome )
Immusoft Corp
Preclinical
ISP-002
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Immusoft Corp
Preclinical
ISX9-CPC
Cardiomyopathy
IPS Heart Inc
Phase 1
ITI-1001
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
Phase 1
ITI-3000
Merkel Cell Carcinoma
Immunomic Therapeutics Inc
Preclinical
ITR-2401
Androgenic Alopecia
Solipharma LLC
IVABRADINE
IVABRADINE
no indication
ANNORA PHARMA
Phase 2
IVB-001
Metabolic Dysfunction-Associated Steatotic Liver Disease…
Invictus Therapeutics Ltd
Phase 1
IVB-003
Pancreatic Cancer
Invictus Therapeutics Ltd
Phase 2
IVMED-80
Keratoconus
$GKOS
GLAUKOS Corp
Phase 1
IVMED-85
Myopia
iVeena Delivery Systems Inc
IVRA
IVRA (MELPHALAN HCL)
no indication
APOTEX
Phase 2
IVS-3001
Epithelial Ovarian Cancer
Invectys SA
Preclinical
IVT-8086
Osteosarcoma
Innova Therapeutics Inc
Phase 2
IVW-1001
Keratoconjunctivitis Sicca (Dry Eye)
iView Therapeutics Inc
Preclinical
IVW-1802
Myopia
iView Therapeutics Inc
Preclinical
IXTV-100
Substance (Drug) Abuse
InterveXion Therapeutics LLC
Marketed
Iheezo
Iheezo (chloroprocaine [INN])
Local Anesthetic Effect
$HROW
HARROW, INC.
Phase 3
IkT-001
Pulmonary Arterial Hypertension
$IKT
Inhibikase Therapeutics, Inc.
